SAFRA CATZ - 25 Mar 2024 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Chief Executive Officer, Director
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Safra Catz (POA Filed 03-21-19)
Issuer symbol
ORCL
Transactions as of
25 Mar 2024
Net transactions value
-$236,267,481
Form type
4
Filing time
27 Mar 2024, 19:02:19 UTC
Previous filing
02 Jan 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $38,082,270 +941,000 +84% $40.47 2,059,592 25 Mar 2024 Direct
transaction ORCL Common Stock Options Exercise $8,128,010 +209,000 +10% $38.89 2,268,592 25 Mar 2024 Direct
transaction ORCL Common Stock Sale $137,487,521 -1,086,967 -48% $126.49 1,181,625 25 Mar 2024 Direct F1, F2
transaction ORCL Common Stock Sale $8,017,539 -63,033 -5.3% $127.20 1,118,592 25 Mar 2024 Direct F1, F3
transaction ORCL Common Stock Options Exercise $20,235,000 +500,000 +45% $40.47 1,618,592 26 Mar 2024 Direct
transaction ORCL Common Stock Options Exercise $11,278,100 +290,000 +18% $38.89 1,908,592 26 Mar 2024 Direct
transaction ORCL Common Stock Sale $99,970,313 -790,000 -41% $126.54 1,118,592 26 Mar 2024 Direct F1, F4
transaction ORCL Common Stock Options Exercise $32,740,230 +809,000 +72% $40.47 1,927,592 27 Mar 2024 Direct
transaction ORCL Common Stock Options Exercise $38,890 +1,000 +0.05% $38.89 1,928,592 27 Mar 2024 Direct
transaction ORCL Common Stock Sale $94,278,487 -754,383 -39% $124.97 1,174,209 27 Mar 2024 Direct F1, F5
transaction ORCL Common Stock Sale $5,670,000 -44,993 -3.8% $126.02 1,129,216 27 Mar 2024 Direct F1, F6
transaction ORCL Common Stock Sale $1,346,120 -10,624 -0.94% $126.71 1,118,592 27 Mar 2024 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -941,000 -42% $0.000000 1,309,000 25 Mar 2024 Common Stock 941,000 $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -209,000 -42% $0.000000 291,000 25 Mar 2024 Common Stock 209,000 $38.89 Direct F8
transaction ORCL Stock Option Options Exercise $0 -500,000 -38% $0.000000 809,000 26 Mar 2024 Common Stock 500,000 $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -290,000 -100% $0.000000 1,000 26 Mar 2024 Common Stock 290,000 $38.89 Direct F8
transaction ORCL Stock Option Options Exercise $0 -809,000 -100% $0.000000* 0 27 Mar 2024 Common Stock 809,000 $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -1,000 -100% $0.000000* 0 27 Mar 2024 Common Stock 1,000 $38.89 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 1, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $126.05 to $127.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $127.055 to $127.45. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $126.00 to $126.935. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $124.4729 to $125.47. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $125.475 to $126.46. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $126.495 to $127.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F8 25% of the shares subject to the option vested annually on each anniversary of the grant date.